Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...

SIR-Spheres® Y-90 resin microspheres are now FDA-approved for unresectable HCC, marking a unique approval for both HCC and mCRC in the U.S. The DOORwaY90 study showed a 98.5% overall response rate and ...

A research team from the Department of Pathology at the University of Hong Kong's LKS Faculty of Medicine (HKUMed) has discovered that atorvastatin, a widely used cholesterol-lowering drug, could ...

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease. But researchers at McMaster University in collaboration with ...

An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy has shown early promise in a Phase I clinical trial for a ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...

In April of this year, Northwell Health performed the first non-invasive liver tumor treatment using histotripsy on Long Island at Glen Cove Hospital. Histotripsy utilizes ultrasound waves to target ...

SEATTLE — What if a tumor can be removed without having to go under the knife? It's possible, thanks to a device that Seattle doctors said, "liquefies" cancer growth in the liver. Providence Swedish ...

MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...